Orient Pharma Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,400	1,223	889.91	511.86	463.34
Revenue Growth (YoY)	14.52%	37.41%	73.86%	10.47%	12.46%
Cost of Revenue	609.66	571.26	421.25	356.51	320.67
Gross Profit	790.72	651.56	468.67	155.35	142.67
Selling, General & Admin	443.73	373.93	341.01	67.83	56.45
Research & Development	79.93	103.72	99.9	129.25	219.72
Operating Expenses	529.66	493.65	444.35	197.09	276.16
Operating Income	261.06	157.91	24.32	-41.74	-133.49
Interest Expense	-7.91	-13.97	-13.9	-7.37	-5.7
Interest & Investment Income	4.34	3.62	1.68	1.09	0.52
Currency Exchange Gain (Loss)	-	5.62	1.07	5.31	1.25
Other Non Operating Income (Expenses)	-12.85	9.94	9.79	1.72	37.33
EBT Excluding Unusual Items	244.65	163.12	22.95	-40.99	-100.09
Gain (Loss) on Sale of Assets	-	-	-0.04	-0.13	-
Asset Writedown	-	-	-	-	-10
Other Unusual Items	-	-	0.01	0.01	-
Pretax Income	244.65	163.12	22.92	-41.11	-110.09
Income Tax Expense	36.21	55.75	0.64	-12.35	-7.44
Net Income	208.44	107.37	22.29	-28.76	-102.65
Net Income to Common	208.44	107.37	22.29	-28.76	-102.65
Net Income Growth	94.12%	381.76%	-	-	-
Shares Outstanding (Basic)	232	223	223	187	187
Shares Outstanding (Diluted)	232	223	223	187	187
Shares Change (YoY)	3.84%	-	19.27%	-0.00%	10.40%
EPS (Basic)	0.90	0.48	0.10	-0.15	-0.55
EPS (Diluted)	0.90	0.48	0.10	-0.15	-0.55
EPS Growth	86.95%	381.76%	-	-	-
Free Cash Flow	324.04	169.68	-157.1	-17.01	-120.1
Free Cash Flow Per Share	1.40	0.76	-0.70	-0.09	-0.64
Gross Margin	56.46%	53.28%	52.66%	30.35%	30.79%
Operating Margin	18.64%	12.91%	2.73%	-8.15%	-28.81%
Profit Margin	14.88%	8.78%	2.50%	-5.62%	-22.16%
Free Cash Flow Margin	23.14%	13.88%	-17.65%	-3.32%	-25.92%
EBITDA	396.67	272.67	138.97	12.43	-82.31
EBITDA Margin	28.33%	22.30%	15.62%	2.43%	-17.76%
D&A For EBITDA	135.61	114.76	114.65	54.17	51.18
EBIT	261.06	157.91	24.32	-41.74	-133.49
EBIT Margin	18.64%	12.91%	2.73%	-8.15%	-28.81%
Effective Tax Rate	14.80%	34.18%	2.77%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.